- CA$6.06bn
- CA$12.24bn
- CA$32.45bn
- 70
- 91
- 25
- 65
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 18,453 | 14,011 | 21,468 | 35,462 | 32,452 |
Cost of Revenue | |||||
Gross Profit | 2,836 | 2,307 | 2,972 | 4,021 | 3,968 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 17,779 | 13,653 | 20,772 | 34,332 | 31,654 |
Operating Profit | 674 | 358 | 696 | 1,130 | 798 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 547 | 154 | 162 | 416 | 508 |
Provision for Income Taxes | |||||
Net Income After Taxes | 414 | 112 | 126 | 346 | 471 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 382 | 82 | 97 | 310 | 471 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 382 | 82 | 97 | 310 | 471 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.03 | 0.548 | 1.18 | 2.54 | 3.32 |
Dividends per Share |